NewslettersImmune Regulation NewsUncategorizedTargeting Toll-Like Receptors on T Cells as a Therapeutic Strategy against TumorsBy Justin.choi - March 25, 2022013The authors summarize the advances in our understanding of the ability of different types of TLRs and their downstream signaling pathways to activate anti-tumor immunity in T cells.[International Immunology] 6445212 BBBBBBBB items 1 apa 0 default asc 1 173306 https://www.stemcellsciencenews.com/wp-content/plugins/zotpress/Abstract